SAD Study to Assess the Safety, Tolerability, PK, and In-Vivo Performance of AMT-126 in Healthy Male and Female Subjects - NCT05476107

Incidence of Treatment-emergent adverse events (safety and tolerability), To assess the in vivo performance of an AMT-126 tablet formulation (Optional, Part 2 only), To assess pharmacokinetics of AMT-126 in healthy volunteers